Evidence map›Paper›PMID 10677351›Full record

ArticleThe Biochemical journal2000

Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP.

T Rahn Landström, J Mei, M Karlsson, V Manganiello, E Degerman

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Fish oil -- how does it reduce plasma triglycerides?Biochimica et biophysica acta · 2012
    Article
  16. Article
  17. Article
  18. From PDE3B to the regulation of energy homeostasis.Current opinion in pharmacology · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T Rahn LandströmSection for Molecular Signalling, Department of Cell and Molecular Biology, P.O. Box 94, Lund University, S-221 00 Lund, Sweden. tova.rahn_landstrom@medkem.lu.se
J Mei
M Karlsson
V Manganiello
E Degerman
Lund University · SE

Funding

Expression, Structure/function, Regulation, and Roles of PDE3 IsoformsZIAHL002540 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MANGANIELLO, VINCENT · 2009 to 2016
$17.0M
Phosphodiesterase 3 IsoformsZ01HL002540 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MANGANIELLO, VINCENT · 1995 to 2008
$4.4M
6 · The paper itself

Abstract

We have used murine 3T3-L1 cells, which differentiate in culture and acquire morphological and biochemical features of mature adipocytes, as a model for studying the expression of cyclic-nucleotide phosphodiesterase (PDE) 3B activity, protein and mRNA during differentiation and during long-term treatment of the cells with tumour necrosis factor alpha (TNF-alpha), a cytokine associated with insulin resistance, and a cAMP analogue, N(6),2'-O-dibutyryl cAMP (dbcAMP). PDE3B activity, protein and mRNA could be detected 4 days after the initiation of differentiation of 3T3-L1 preadipocytes. Treatment of 3T3-L1 adipocytes with 10 ng/ml TNF-alpha for 24 h produced a maximal (50%) decrease in PDE3B activity, protein and mRNA, which was well correlated with both activation of protein kinase A (PKA) and stimulation of lipolysis, presumably reflecting an increase in intracellular cAMP concentration. To investigate the effect of cAMP on PDE3B we treated 3T3-L1 adipocytes with dbcAMP. After 4 h with 0.5 mM dbcAMP, PDE3B activity was decreased by 80%, which was also correlated with a decrease in PDE3B protein and mRNA. This effect was abolished in the presence of N-[2-(bromocinnamylamino)ethyl]-5-isoquinolinesulphonamide] (H-89), a specific PKA inhibitor. We conclude that the lipolytic effect of TNF-alpha involves the down-regulation of PDE3B, which is associated with increased activation of PKA, presumably owing to increased levels of cAMP. In addition, the PKA activation induced by dbcAMP resulted in the down-regulation of PDE3B. These results, which suggest that PDE3B is a novel target for long-term regulation by TNF-alpha and cAMP, could contribute to the understanding of the mechanisms of insulin resistance.

Indexed as

3',5'-Cyclic-AMP Phosphodiesterases3T3 CellsAdipocytesAnimalsCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 3Down-RegulationGene Expression Regulation, EnzymologicMiceTumor Necrosis Factor-alpha3',5'-Cyclic-AMP PhosphodiesterasesCyclic AMPCyclic Nucleotide Phosphodiesterases, Type 3Pde3b protein, mouseTumor Necrosis Factor-alpha

Identifiers

PMID10677351
PMCPMC1220858
OpenAlexW2001341569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.